ArticleInternational journal of molecular sciences2015

The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model Mice.

Takayasu Ideta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.